Tevogen Board to Evaluate One-Time Special Cash Dividend

• Tevogen Bio Holdings Board to evaluate one-time special cash dividend • Dividend contingent on achieving revenue and earnings targets • Decision subject to financial performance and Board approval • No assurance of dividend payment • Dividend would be best use of capital at the time • Solvency laws, including Delaware General Corporation Law, must be complied with • Final decision to be made by the Board of Directors